{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:19:01Z","timestamp":1788297541802,"version":"build-2803163510"},"reference-count":157,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009580","name":"Chinese PLA General Hospital","doi-asserted-by":"publisher","award":["NCRCG-PLAGH-2022009"],"award-info":[{"award-number":["NCRCG-PLAGH-2022009"]}],"id":[{"id":"10.13039\/501100009580","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.intimp.2023.110530","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T05:59:40Z","timestamp":1687240780000},"page":"110530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Role of the CXCR6\/CXCL16 axis in autoimmune diseases"],"prefix":"10.1016","volume":"121","author":[{"given":"Nandi","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuangzhuang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2023.110530_b0005","doi-asserted-by":"crossref","first-page":"e14593","DOI":"10.1371\/journal.pone.0014593","article-title":"Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer","volume":"6","author":"Baird","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.110530_b0010","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.110530_b0015","doi-asserted-by":"crossref","first-page":"106314","DOI":"10.1016\/j.intimp.2020.106314","article-title":"The role of chemokines and chemokine receptors in multiple sclerosis","volume":"83","author":"Cui","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110530_b0020","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41584-019-0323-6","article-title":"Chemokines in rheumatic diseases: pathogenic role and therapeutic implications","volume":"15","author":"Miyabe","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110530_b0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imr.12757","article-title":"Exploring the complex role of chemokines and chemoattractants in vivo on leukocyte dynamics","volume":"289","author":"David","year":"2019","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020185","article-title":"Involvement of CXCR4 in normal and abnormal development","volume":"8","author":"Kawaguchi","year":"2019","journal-title":"Cells"},{"issue":"18","key":"10.1016\/j.intimp.2023.110530_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189804","article-title":"Chemokine-directed tumor microenvironment modulation in cancer immunotherapy","volume":"22","author":"Bule","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2023.110530_b0040","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.pan.2018.07.011","article-title":"Functions of the CXC ligand family in the pancreatic tumor microenvironment","volume":"18","author":"Lee","year":"2018","journal-title":"Pancreatology"},{"key":"10.1016\/j.intimp.2023.110530_b0045","doi-asserted-by":"crossref","first-page":"4270957","DOI":"10.1155\/2020\/4270957","article-title":"Transcriptional expressions of CXCL9\/10\/12\/13 as prognosis factors in breast cancer","volume":"2020","author":"Li","year":"2020","journal-title":"J. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.110530_b0055","doi-asserted-by":"crossref","unstructured":"Huynh C, Dingemanse J, Meyer Zu Schwabedissen HE, Sidharta PN. Relevance of the CXCR4\/CXCR7-CXCL12 axis and its effect in pathophysiological conditions. Pharmacol Res. 2020. 161: 105092.","DOI":"10.1016\/j.phrs.2020.105092"},{"key":"10.1016\/j.intimp.2023.110530_b0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/bs.ai.2018.02.002","article-title":"Chemokines: Critical regulators of memory T cell development, maintenance, and function","volume":"138","author":"Rahimi","year":"2018","journal-title":"Adv. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110530_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042168","article-title":"CXCR2 receptor: Regulation of expression, signal transduction, and involvement in cancer","volume":"23","author":"Korbecki","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nri722","article-title":"Chemokine receptors: multifaceted therapeutic targets","volume":"2","author":"Proudfoot","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2023.110530_b0075","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.4049\/jimmunol.166.8.5145","article-title":"Expression cloning of the STRL33\/BONZO\/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines","volume":"166","author":"Wilbanks","year":"2001","journal-title":"J. Immunol."},{"issue":"52","key":"10.1016\/j.intimp.2023.110530_b0080","doi-asserted-by":"crossref","first-page":"40663","DOI":"10.1074\/jbc.C000761200","article-title":"Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages","volume":"275","author":"Shimaoka","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2023.110530_b0085","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/79738","article-title":"A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo","volume":"1","author":"Matloubian","year":"2000","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0090","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.4049\/jimmunol.174.2.1055","article-title":"CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver","volume":"174","author":"Heydtmann","year":"2005","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110530_b0095","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1189\/jlb.1204733","article-title":"Distribution and kinetics of SR-PSOX\/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+ T cells","volume":"77","author":"Tabata","year":"2005","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110530_b0100","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4049\/jimmunol.171.4.1647","article-title":"Cutting edge: SR-PSOX\/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain","volume":"171","author":"Shimaoka","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110530_b0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/B978-0-12-417197-8.00009-2","article-title":"Constitutively active chemokine CXC receptors","volume":"70","author":"Han","year":"2014","journal-title":"Adv. Pharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110530_b0110","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.apsb.2020.09.004","article-title":"Precise delivery of obeticholic acid via nanoapproach for triggering natural killer T cell-mediated liver cancer immunotherapy","volume":"10","author":"Ji","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2023.110530_b0115","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12885-015-1446-z","article-title":"Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival","volume":"15","author":"Hald","year":"2015","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2023.110530_b0120","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/intimm\/dxm083","article-title":"CXCL16 is a novel mediator of the innate immunity of epidermal keratinocytes","volume":"19","author":"Tohyama","year":"2007","journal-title":"Int. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110530_b0125","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.4049\/jimmunol.172.10.6362","article-title":"The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10","volume":"172","author":"Abel","year":"2004","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110530_b0130","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.4049\/jimmunol.172.6.3678","article-title":"A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16","volume":"172","author":"Gough","year":"2004","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0135","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ejca.2008.10.023","article-title":"Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients","volume":"45","author":"Gutwein","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2023.110530_b0140","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbrc.2007.04.100","article-title":"Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by alpha- and gamma-secretases","volume":"358","author":"Schulte","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0145","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.atherosclerosis.2011.04.021","article-title":"SR-PSOX at sites predisposed to atherosclerotic lesion formation mediates monocyte-endothelial cell adhesion","volume":"217","author":"Hofnagel","year":"2011","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0150","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1189\/jlb.1003465","article-title":"Cell surface-anchored SR-PSOX\/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells","volume":"75","author":"Shimaoka","year":"2004","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0155","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4049\/jimmunol.170.3.1136","article-title":"Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues","volume":"170","author":"Nakayama","year":"2003","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110530_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073490","article-title":"The role of CXCL16 in the pathogenesis of cancer and other diseases","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0165","doi-asserted-by":"crossref","first-page":"e0173486","DOI":"10.1371\/journal.pone.0173486","article-title":"The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion","volume":"12","author":"Koenen","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.intimp.2023.110530_b0170","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003100","article-title":"CXCR6 is required for antitumor efficacy of intratumoral CD8(+) T cell","volume":"9","author":"Wang","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0175","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1089\/scd.2011.0025","article-title":"Chemokines stimulate bidirectional migration of human mesenchymal stem cells across bone marrow endothelial cells","volume":"21","author":"Smith","year":"2012","journal-title":"Stem Cells Dev."},{"issue":"6","key":"10.1016\/j.intimp.2023.110530_b0180","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCHEARTFAILURE.108.821074","article-title":"Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling","volume":"2","author":"Dahl","year":"2009","journal-title":"Circ. Heart Fail."},{"issue":"1","key":"10.1016\/j.intimp.2023.110530_b0185","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/cvr\/cvn071","article-title":"High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins","volume":"79","author":"Smith","year":"2008","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.intimp.2023.110530_b0190","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1074\/jbc.M311660200","article-title":"CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation","volume":"279","author":"Chandrasekar","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0195","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbrc.2008.03.088","article-title":"The role of CXCL16 and its processing metalloproteinases ADAM10 and ADAM17 in the proliferation and migration of human mesangial cells","volume":"370","author":"Schramme","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0200","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1128\/JVI.79.3.1686-1700.2005","article-title":"CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia","volume":"79","author":"Blaak","year":"2005","journal-title":"J. Virol."},{"issue":"6639","key":"10.1016\/j.intimp.2023.110530_b0205","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/40789","article-title":"A new SIV co-receptor, STRL33","volume":"388","author":"Alkhatib","year":"1997","journal-title":"Nature"},{"issue":"6639","key":"10.1016\/j.intimp.2023.110530_b0210","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/40894","article-title":"Expression cloning of new receptors used by simian and human immunodeficiency viruses","volume":"388","author":"Deng","year":"1997","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.intimp.2023.110530_b0215","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1084\/jem.185.11.2015","article-title":"STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1","volume":"185","author":"Liao","year":"1997","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.intimp.2023.110530_b0220","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0960-9822(06)00292-2","article-title":"TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function","volume":"7","author":"Loetscher","year":"1997","journal-title":"Curr. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110530_b0225","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"Zlotnik","year":"2012","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.intimp.2023.110530_b0230","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.4049\/jimmunol.165.6.3284","article-title":"The primate lentiviral receptor Bonzo\/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse","volume":"165","author":"Unutmaz","year":"2000","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110530_b0235","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.4049\/jimmunol.1202909","article-title":"Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis","volume":"190","author":"Wehr","year":"2013","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110530_b0240","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.4049\/jimmunol.177.11.7833","article-title":"Evidence for NK cell subsets based on chemokine receptor expression","volume":"177","author":"Berahovich","year":"2006","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110530_b0245","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI11902","article-title":"Bonzo\/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential","volume":"107","author":"Kim","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.intimp.2023.110530_b0250","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2567.2007.02603.x","article-title":"CXCR6 is expressed on T cells in both T helper type 1 (Th1) inflammation and allergen-induced Th2 lung inflammation but is only a weak mediator of chemotaxis","volume":"121","author":"Latta","year":"2007","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.intimp.2023.110530_b0255","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.intimp.2023.110530_b0260","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.prp.2018.07.009","article-title":"Tumor-associated macrophages promote the metastasis of ovarian carcinoma cells by enhancing CXCL16\/CXCR6 expression","volume":"214","author":"Hong","year":"2018","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.intimp.2023.110530_b0265","doi-asserted-by":"crossref","first-page":"405","DOI":"10.12659\/MSM.906230","article-title":"High CXC chemokine ligand 16 (CXCL16) expression promotes proliferation and metastasis of lung cancer via regulating the NF-\u03baB pathway","volume":"24","author":"Liang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.intimp.2023.110530_b0270","doi-asserted-by":"crossref","first-page":"106035","DOI":"10.1016\/j.intimp.2019.106035","article-title":"CXCL16\/CXCR6 axis promotes bleomycin-induced fibrotic process in MRC-5 cells via the PI3K\/AKT\/FOXO3a pathway","volume":"81","author":"Ma","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110530_b0275","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/CIRCRESAHA.112.276444","article-title":"The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase\/Akt signaling","volume":"111","author":"Borst","year":"2012","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0280","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/1933719118776797","article-title":"Activation of the CXCL16\/CXCR6 Axis by TNF-\u03b1 contributes to ectopic endometrial stromal cells migration and invasion","volume":"26","author":"Peng","year":"2019","journal-title":"Reprod. Sci."},{"issue":"16","key":"10.1016\/j.intimp.2023.110530_b0285","doi-asserted-by":"crossref","first-page":"14165","DOI":"10.18632\/oncotarget.3690","article-title":"CXCL16\/CXCR6 chemokine signaling mediates breast cancer progression by pERK1\/2-dependent mechanisms","volume":"6","author":"Xiao","year":"2015","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.intimp.2023.110530_b0290","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1016\/j.apsb.2022.03.012","article-title":"CXCR6-based immunotherapy in autoimmune, cancer and inflammatory infliction","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.intimp.2023.110530_b0295","doi-asserted-by":"crossref","first-page":"102846","DOI":"10.1016\/j.autrev.2021.102846","article-title":"CCR6-CCL20 axis as a therapeutic target for autoimmune diseases","volume":"20","author":"Meitei","year":"2021","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0300","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","article-title":"Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases","volume":"13","author":"Antonelli","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0305","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11011-020-00648-6","article-title":"A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis","volume":"36","author":"Ghafouri-Fard","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0310","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/bpa.12454","article-title":"Multiple sclerosis animal models: a clinical and histopathological perspective","volume":"27","author":"Kipp","year":"2017","journal-title":"Brain Pathol."},{"key":"10.1016\/j.intimp.2023.110530_b0315","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/7651_2014_88","article-title":"Experimental autoimmune encephalomyelitis in mice","volume":"1304","author":"Terry","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0320","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3109\/1547691X.2015.1101512","article-title":"St. John's wort and its component hyperforin alleviate experimental autoimmune encephalomyelitis through expansion of regulatory T-cells","volume":"13","author":"Nosratabadi","year":"2016","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.intimp.2023.110530_b0325","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.msard.2019.01.025","article-title":"Acylated and deacylated quillaja saponin-21 adjuvants have opposite roles when utilized for immunization of C57BL\/6 mice model with MOG(35\u201355) peptide","volume":"29","author":"Heidari","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0330","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","article-title":"Multiple sclerosis: experimental models and reality","volume":"133","author":"Lassmann","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0335","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2478\/jtim-2022-0024","article-title":"Aberrant energy metabolism in alzheimer's disease","volume":"10","author":"Yu","year":"2022","journal-title":"J. Transl. Int. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.110530_b0340","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8010120","article-title":"The diversity of encephalitogenic CD4+ T cells in multiple sclerosis and its animal models","volume":"8","author":"Segal","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2023.110530_b0345","doi-asserted-by":"crossref","first-page":"659206","DOI":"10.1155\/2014\/659206","article-title":"Chemokines and chemokine receptors in multiple sclerosis","volume":"2014","author":"Cheng","year":"2014","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.intimp.2023.110530_b0350","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/1742-2094-9-243","article-title":"Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes","volume":"9","author":"Berghmans","year":"2012","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.intimp.2023.110530_b0355","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jneuroim.2015.11.021","article-title":"New insights into the role of stromal cell-derived factor 1 (SDF-1\/CXCL12) in the pathophysiology of multiple sclerosis","volume":"290","author":"Khorramdelazad","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"41","key":"10.1016\/j.intimp.2023.110530_b0360","doi-asserted-by":"crossref","first-page":"20635","DOI":"10.1073\/pnas.1905762116","article-title":"SerpinB1 controls encephalitogenic T helper cells in neuroinflammation","volume":"116","author":"Hou","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2023.110530_b0365","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jim.2009.09.007","article-title":"Two-photon laser scanning microscopy imaging of intact spinal cord and cerebral cortex reveals requirement for CXCR6 and neuroinflammation in immune cell infiltration of cortical injury sites","volume":"352","author":"Kim","year":"2010","journal-title":"J. Immunol. Methods"},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0370","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.4049\/jimmunol.173.3.1620","article-title":"Critical roles of CXC chemokine ligand 16\/scavenger receptor that binds phosphatidylserine and oxidized lipoprotein in the pathogenesis of both acute and adoptive transfer experimental autoimmune encephalomyelitis","volume":"173","author":"Fukumoto","year":"2004","journal-title":"J. Immunol."},{"issue":"26","key":"10.1016\/j.intimp.2023.110530_b0375","doi-asserted-by":"crossref","first-page":"26807","DOI":"10.1074\/jbc.C400163200","article-title":"Chemokines generally exhibit scavenger receptor activity through their receptor-binding domain","volume":"279","author":"Shimaoka","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0380","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1189\/jlb.0613331","article-title":"SerpinB1 regulates homeostatic expansion of IL-17+ \u03b3\u03b4 and CD4+ Th17 cells","volume":"95","author":"Zhao","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2023.110530_b0385","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaut.2015.08.006","article-title":"The protease cathepsin L regulates Th17 cell differentiation","volume":"65","author":"Hou","year":"2015","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.intimp.2023.110530_b0390","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/brain\/awaa117","article-title":"Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions","volume":"143","author":"Fransen","year":"2020","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.intimp.2023.110530_b0395","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.immuni.2019.04.006","article-title":"Fate-mapping of GM-CSF expression identifies a discrete subset of inflammation-driving T helper cells regulated by cytokines IL-23 and IL-1\u03b2","volume":"50","author":"Komuczki","year":"2019","journal-title":"Immunity"},{"issue":"258","key":"10.1016\/j.intimp.2023.110530_b0400","doi-asserted-by":"crossref","first-page":"pe3","DOI":"10.1126\/scisignal.2003898","article-title":"Inflammatory cytokines at the summits of pathological signal cascades in brain diseases","volume":"6","author":"Steinman","year":"2013","journal-title":"Sci. Signal."},{"issue":"4","key":"10.1016\/j.intimp.2023.110530_b0405","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1096\/fj.09-141978","article-title":"Cellular mechanisms of IL-17-induced blood-brain barrier disruption","volume":"24","author":"Huppert","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2023.110530_b0410","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaut.2018.10.020","article-title":"Etiopathogenesis of autoimmune hepatitis","volume":"95","author":"Floreani","year":"2018","journal-title":"J. Autoimmun."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2023.110530_b0415","doi-asserted-by":"crossref","first-page":"J187","DOI":"10.1016\/j.jaut.2011.11.012","article-title":"The X chromosome and immune associated genes","volume":"38","author":"Bianchi","year":"2012","journal-title":"J. Autoimmun."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2023.110530_b0420","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jns.2009.04.022","article-title":"Gender bias in autoimmune diseases: X chromosome inactivation in women with multiple sclerosis","volume":"286","author":"Knudsen","year":"2009","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2023.110530_b0425","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110530_b0430","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gut.2010.235259","article-title":"British society of gastroenterology (BSG) guidelines for management of autoimmune hepatitis","volume":"60","author":"Gleeson","year":"2011","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0435","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0046-8177(72)80072-8","article-title":"Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution","volume":"3","author":"Baggenstoss","year":"1972","journal-title":"Hum. Pathol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110530_b0440","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/BF01076196","article-title":"Severe chronic active liver disease. Prognostic significance of initial morphologic patterns","volume":"22","author":"Schalm","year":"1977","journal-title":"Am. J. Dig. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0445","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1089-3261(02)00022-3","article-title":"The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants","volume":"6","author":"Carpenter","year":"2002","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.intimp.2023.110530_b0450","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0455","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2478\/jtim-2021-0056","article-title":"Novel insights into alcoholic liver disease: Iron overload, iron sensing and hemolysis","volume":"10","author":"Mueller","year":"2022","journal-title":"J. Transl. Int. Med."},{"issue":"4","key":"10.1016\/j.intimp.2023.110530_b0460","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2478\/jtim-2022-0068","article-title":"Focal liver lesions other than hepatocellular carcinoma in cirrhosis: Diagnostic challenges","volume":"10","author":"M\u00f6ller","year":"2022","journal-title":"J. Transl. Int. Med."},{"issue":"7","key":"10.1016\/j.intimp.2023.110530_b0465","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8147","key":"10.1016\/j.intimp.2023.110530_b0470","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(79)92178-0","article-title":"The nature of piecemeal necrosis in chronic active hepatitis","volume":"2","author":"Kerr","year":"1979","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.intimp.2023.110530_b0475","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1034\/j.1600-0676.2001.021004272.x","article-title":"Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis","volume":"21","author":"Fox","year":"2001","journal-title":"Liver"},{"issue":"1","key":"10.1016\/j.intimp.2023.110530_b0480","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1568-9972(02)00125-8","article-title":"Apoptosis and the liver: relation to autoimmunity and related conditions","volume":"2","author":"Bai","year":"2003","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2023.110530_b0485","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/apt.12592","article-title":"Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis","volume":"39","author":"Czaja","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.intimp.2023.110530_b0490","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3748\/wjg.v20.i10.2515","article-title":"Hepatic inflammation and progressive liver fibrosis in chronic liver disease","volume":"20","author":"Czaja","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0495","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.hbpd.2021.04.007","article-title":"Cross-talk between hepatic stellate cells and T lymphocytes in liver fibrosis","volume":"20","author":"Li","year":"2021","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.intimp.2023.110530_b0500","doi-asserted-by":"crossref","unstructured":"Chemokine\/chemokine receptor nomenclature. J Immunol Methods. 2002. 262(1-2): 1-3.","DOI":"10.1016\/S0022-1759(02)00042-X"},{"key":"10.1016\/j.intimp.2023.110530_b0505","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1034\/j.1600-065X.2003.00067.x","article-title":"Chemokines in the systemic organization of immunity","volume":"195","author":"Campbell","year":"2003","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0510","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2741\/3261","article-title":"Chemokines and chemokine receptors: an overview","volume":"14","author":"Bonecchi","year":"2009","journal-title":"Front. Biosci. (Landmark Ed)."},{"issue":"4","key":"10.1016\/j.intimp.2023.110530_b0515","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1371\/journal.pbio.0030113","article-title":"Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids","volume":"3","author":"Geissmann","year":"2005","journal-title":"PLoS Biol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0520","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.4049\/jimmunol.173.2.1417","article-title":"Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis","volume":"173","author":"de Lalla","year":"2004","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110530_b0525","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23983","article-title":"Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells","volume":"53","author":"Jin","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0530","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/apt.12825","article-title":"Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets","volume":"40","author":"Czaja","year":"2014","journal-title":"Aliment Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2023.110530_b0535","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/abbs\/gmx040","article-title":"CXCL16 deficiency attenuates acetaminophen-induced hepatotoxicity through decreasing hepatic oxidative stress and inflammation in mice","volume":"49","author":"Wang","year":"2017","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"9","key":"10.1016\/j.intimp.2023.110530_b0540","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/gutjnl-2011-301857","article-title":"NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease","volume":"61","author":"Syn","year":"2012","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0545","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.23019","article-title":"Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production","volume":"50","author":"Omenetti","year":"2009","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.intimp.2023.110530_b0550","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1210\/jc.2018-00762","article-title":"CXC motif ligand 16 promotes nonalcoholic fatty liver disease progression via hepatocyte-stellate cell crosstalk","volume":"103","author":"Jiang","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.intimp.2023.110530_b0555","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1756-9966-32-51","article-title":"Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-\u03baB pathways induced by paracrine cytokines","volume":"32","author":"Wang","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2023.110530_b0560","doi-asserted-by":"crossref","first-page":"1100869","DOI":"10.3389\/fimmu.2023.1100869","article-title":"Chemokines and chemokine receptors as promising targets in rheumatoid arthritis","volume":"14","author":"Murayama","year":"2023","journal-title":"Front. Immunol."},{"issue":"23","key":"10.1016\/j.intimp.2023.110530_b0565","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2023.110530_b0570","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-065X.2008.00626.x","article-title":"Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics","volume":"223","author":"Feldmann","year":"2008","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.intimp.2023.110530_b0575","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1002\/art.21301","article-title":"Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis","volume":"52","author":"Nanki","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0580","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2177\/jsci.39.172","article-title":"Treatment for rheumatoid arthritis by chemokine blockade","volume":"39","author":"Nanki","year":"2016","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"issue":"5","key":"10.1016\/j.intimp.2023.110530_b0585","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/ar2823","article-title":"Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis","volume":"11","author":"Nanki","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2023.110530_b0590","doi-asserted-by":"crossref","unstructured":"Koch AE. Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis. 2003. 62 Suppl 2(Suppl 2): ii60-7.","DOI":"10.1136\/ard.62.suppl_2.ii60"},{"key":"10.1016\/j.intimp.2023.110530_b0595","doi-asserted-by":"crossref","first-page":"174500","DOI":"10.1016\/j.ejphar.2021.174500","article-title":"Angiogenesis as a potential treatment strategy for rheumatoid arthritis","volume":"910","author":"Wang","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110530_b0600","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/art.37981","article-title":"Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis : studies in mice with K\/BxN serum-induced arthritis","volume":"65","author":"Isozaki","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.intimp.2023.110530_b0605","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/art.22706","article-title":"The role of vascular cell adhesion molecule 1\/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium","volume":"56","author":"Silverman","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0610","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/art.21662","article-title":"CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway","volume":"54","author":"Ruth","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2023.110530_b0615","doi-asserted-by":"crossref","first-page":"601639","DOI":"10.3389\/fimmu.2020.601639","article-title":"Evaluation of proteoforms of the transmembrane chemokines CXCL16 and CX3CL1, their receptors, and their processing metalloproteinases ADAM10 and ADAM17 in proliferative diabetic retinopathy","volume":"11","author":"Abu El-Asrar","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0620","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2007.11.059","article-title":"Microbial influences in inflammatory bowel diseases","volume":"134","author":"Sartor","year":"2008","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.intimp.2023.110530_b0625","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/ibd.21306","article-title":"Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation","volume":"16","author":"Diegelmann","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"issue":"11","key":"10.1016\/j.intimp.2023.110530_b0630","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/gut.2010.221879","article-title":"SR-PSOX\/CXCL16 plays a critical role in the progression of colonic inflammation","volume":"60","author":"Uza","year":"2011","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.intimp.2023.110530_b0635","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ng.717","article-title":"Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci","volume":"42","author":"Franke","year":"2010","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.intimp.2023.110530_b0640","doi-asserted-by":"crossref","first-page":"e65488","DOI":"10.1371\/journal.pone.0065488","article-title":"Distinct roles for CXCR6(+) and CXCR6(-) CD4(+) T cells in the pathogenesis of chronic colitis","volume":"8","author":"Mandai","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.intimp.2023.110530_b0645","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/01.ATV.0000124102.11472.36","article-title":"CXCL16\/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions","volume":"24","author":"Wuttge","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"28","key":"10.1016\/j.intimp.2023.110530_b0650","doi-asserted-by":"crossref","first-page":"26263","DOI":"10.1074\/jbc.M502586200","volume":"280","author":"Chandrasekar","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0655","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1074-7613(00)80038-2","article-title":"Impaired on\/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies","volume":"10","author":"Kontoyiannis","year":"1999","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2023.110530_b0660","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/gast.2002.30329","article-title":"Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells","volume":"122","author":"Brand","year":"2002","journal-title":"Gastroenterology"},{"issue":"3 Suppl 2","key":"10.1016\/j.intimp.2023.110530_b0665","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jaad.2005.10.057","article-title":"Innate and adaptive immunity and the pathophysiology of psoriasis","volume":"54","author":"Gaspari","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9583","key":"10.1016\/j.intimp.2023.110530_b0670","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2023.110530_b0675","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physiolgenomics.00157.2002","article-title":"Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array","volume":"13","author":"Zhou","year":"2003","journal-title":"Physiol. Genomics"},{"issue":"1","key":"10.1016\/j.intimp.2023.110530_b0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2004.02310.x","article-title":"Immunopathogenic mechanisms in psoriasis","volume":"135","author":"Gudjonsson","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110530_b0685","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-2133.2004.05863.x","article-title":"Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late","volume":"150","author":"Vissers","year":"2004","journal-title":"Br. J. Dermatol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110530_b0690","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.4049\/jimmunol.181.7.4733","article-title":"Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis","volume":"181","author":"Kryczek","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0695","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1051\/medsci\/2006222153","article-title":"Innate antimicrobial peptides in the skin","volume":"22","author":"Schr\u00f6der","year":"2006","journal-title":"Med. Sci. (Paris)"},{"issue":"6","key":"10.1016\/j.intimp.2023.110530_b0700","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.clindermatol.2007.08.016","article-title":"Innate immunity and antimicrobial defense systems in psoriasis","volume":"25","author":"B\u00fcchau","year":"2007","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.intimp.2023.110530_b0705","first-page":"69","article-title":"Chemokines and inflammatory skin diseases","volume":"45","author":"Homey","year":"2004","journal-title":"Ernst. Schering Res. Found Workshop"},{"issue":"6","key":"10.1016\/j.intimp.2023.110530_b0710","first-page":"497","article-title":"Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin","volume":"17","author":"Begon","year":"2007","journal-title":"Eur. J. Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110530_b0715","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0923-1811(02)00105-6","article-title":"Expression of functional Toll-like receptor 2 on human epidermal keratinocytes","volume":"30","author":"Kawai","year":"2002","journal-title":"J. Dermatol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2023.110530_b0720","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.jid.5700751","article-title":"Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin","volume":"127","author":"Scholz","year":"2007","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110530_b0725","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1365-2133.2008.08513.x","article-title":"Overexpression of ADAM 10 and ADAM 12 in lesional psoriatic skin","volume":"158","author":"Oh","year":"2008","journal-title":"Br. J. Dermatol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110530_b0730","doi-asserted-by":"crossref","first-page":"8064","DOI":"10.4049\/jimmunol.178.12.8064","article-title":"Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes","volume":"178","author":"Hundhausen","year":"2007","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0735","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4161\/derm.1.2.7750","article-title":"Overexpression of CXCL16 in lesional psoriatic skin","volume":"1","author":"Oh","year":"2009","journal-title":"Dermatoendocrinol"},{"issue":"6","key":"10.1016\/j.intimp.2023.110530_b0740","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1189\/jlb.0106038","article-title":"Emerging roles for ectodomain shedding in the regulation of inflammatory responses","volume":"79","author":"Garton","year":"2006","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110530_b0745","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jid.2017.08.041","article-title":"Toll-like receptor-mediated upregulation of CXCL16 in psoriasis orchestrates neutrophil activation","volume":"138","author":"Steffen","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110530_b0750","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/art.21004","article-title":"Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints","volume":"52","author":"van der Voort","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.intimp.2023.110530_b0755","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1172\/JCI13543","article-title":"Rules of chemokine receptor association with T cell polarization in vivo","volume":"108","author":"Kim","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2023.110530_b0760","doi-asserted-by":"crossref","first-page":"916701","DOI":"10.3389\/fimmu.2022.916701","article-title":"Metabolic syndrome in psoriasis is associated with upregulation of CXCL16 on monocytes and a dysbalance in innate lymphoid cells","volume":"13","author":"Schielke","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110530_b0765","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/hq1001.096652","article-title":"Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions","volume":"21","author":"Minami","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110530_b0770","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1073\/pnas.76.1.333","article-title":"Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition","volume":"76","author":"Goldstein","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.intimp.2023.110530_b0775","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.105.540583","article-title":"Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis","volume":"114","author":"Aslanian","year":"2006","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.intimp.2023.110530_b0780","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/cvr\/cvy135","article-title":"Functional role of endothelial CXCL16\/CXCR6-platelet-leucocyte axis in angiotensin II-associated metabolic disorders","volume":"114","author":"Collado","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.intimp.2023.110530_b0785","doi-asserted-by":"crossref","first-page":"154081","DOI":"10.1016\/j.cyto.2017.06.008","article-title":"CXCL16\/CXCR6-mediated adhesion of human peripheral blood mononuclear cells to inflamed endothelium","volume":"122","author":"Linke","year":"2019","journal-title":"Cytokine"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923008536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923008536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:09:19Z","timestamp":1761588559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923008536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":157,"alternative-id":["S1567576923008536"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110530","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the CXCR6\/CXCL16 axis in autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110530"}}